Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Longmian Avenue, 639, Nanjing, Jiangsu 211198, China.
Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, 211198, China.
Biomed Pharmacother. 2018 Jun;102:689-698. doi: 10.1016/j.biopha.2018.03.140. Epub 2018 Apr 5.
Cardiovascular diseases (CVDs) are considered as the major reason for mortality and morbidity worldwide. Substantial evidence suggests that increased oxidative stress plays a significant role in the pathogenesis of CVDs, including atherosclerosis, hypertension, vascular endothelial dysfunction and ischemic heart disease. Cellular oxidative stress results in the release of toxic free radicals by endothelial cells and vascular smooth muscle cells that interact with cell components such as protein, DNA or lipid resulting in cardiovascular pathology. Silymarin has antioxidant activities against CVDs and offers protection against oxidative stress-induced hypertension, atherosclerosis and cardiac toxicity. We present a comprehensive review regarding the oxidative stress and protective effects of silymarin in CVDs management. We also aim to provide mechanistic insight of the mechanisms of silymarin action in oxidative stress-induced CVDs.
心血管疾病(CVDs)被认为是全球范围内死亡和发病的主要原因。大量证据表明,氧化应激增加在 CVDs 的发病机制中起着重要作用,包括动脉粥样硬化、高血压、血管内皮功能障碍和缺血性心脏病。细胞氧化应激导致内皮细胞和血管平滑肌细胞释放有毒自由基,这些自由基与蛋白质、DNA 或脂质等细胞成分相互作用,导致心血管病理学。水飞蓟素具有抗氧化活性,可预防 CVDs,并可预防氧化应激引起的高血压、动脉粥样硬化和心脏毒性。我们就氧化应激和水飞蓟素在 CVDs 管理中的保护作用进行了全面综述。我们还旨在提供水飞蓟素在氧化应激诱导的 CVDs 中作用机制的机制见解。